Ledger.Open graph →
SEC Form D · filed September 5, 2017

Antidote Therapeutics, Inc

Offering
$432K
Sold
$432K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GAITHERSBURG, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Kenneth C. Carter · Rockville, MDDirectorMatthew W. Kalnik, Phd · Gaithersburg, MDExec · DirectorToni Pinkerton · Grand Cayman, Cayman IslandsDirectorAlexander Skidanov · San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗